To Explore the Mechanism of Hawthorn in the Intervention of Hyperlipidemia Based on the Gene Expression Omnibus and Network Pharmacology

被引:0
作者
Song, Xuejing [1 ]
Li, Hong [1 ]
Liang, Y. [1 ]
Chen, J. [2 ]
Zhao, L. Z. [3 ]
Tang, C. [3 ]
机构
[1] Southwest Med Univ, Dept Pharmacol, Luzhou 646099, Sichuan, Peoples R China
[2] Luzhou Hosp Tradit Chinese Med, Dept Pharmacol, Luzhou, Peoples R China
[3] Southwest Med Univ, Dept Cardiol, Affiliated Tradit Chinese Med Hosp, Luzhou 646000, Sichuan, Peoples R China
关键词
Network pharmacology; hawthorn; hyperlipidemia; gene expression omnibus database; UPDATE; IDENTIFICATION; INFLAMMATION; CYTOSCAPE;
D O I
10.36468/pharmaceutical-sciences.spl.655
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A common clinical treatment for hyperlipidemia in China is hawthorn, a traditional Chinese herb. However, few researches have been done on its active ingredients and their possible mechanisms for treating hyperlipidemia. The active chemical constituents of hawthorn were obtained from the encyclopedia of traditional Chinese medicine, the bioavailability and druglikeness properties of each active ingredient of hawthorn were analyzed using SwissADME and their possible targets of action were predicted using SwissTargetPrediction and PharmMapper. Then, we used the Gene Expression Omnibus-related gene microarray data to mine the differentially expressed genes for hyperlipidemia. Meanwhile, we collected relevant targets of hyperlipidemia through the DrugBank, Online Mendelian Inheritance in Man, GeneCards, DisGeNET and Therapeutic Target Database. Based on this data, a component-target-disease pathway and a protein-protein interaction networks were constructed using search tool for the retrieval of interacting genes/proteins. Finally, Metascape was systematically used to analyze the targets of hawthorn intervention in hyperlipidemia. A total of 8 active components and 312 hawthorn targets were gathered and 343 prospective targets associated with hyperlipidemia were predicted, 25 of which shared targets with hawthorn-related targets. Gene ontology enrichment analysis revealed that the mechanism of action of hawthorn in intervention of hyperlipidemia lies in the regulation of lipid metabolism, nutrition level, hormone level and cholesterol transport process. The Kyoto encyclopedia of genes and genomes enrichment analysis revealed that the peroxisome proliferator activated receptor signaling pathway contained the majority of the core targets. Molecular docking verified that hawthorn could bind closely to the core targets. According to the findings of network pharmacology and enrichment analysis, we predicted that the main active components of hawthorn to intervene in hyperlipidemia are epicatechin, officinalic acid and quercetin, which mainly intervene in hyperlipidemia through the peroxisome proliferator activated receptor signaling pathway.
引用
收藏
页码:146 / 158
页数:13
相关论文
共 50 条
  • [21] Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of squalene against inflammation
    Shana Sara Luke
    M. Naveen Raj
    Suraj Ramesh
    N. Prasanth Bhatt
    [J]. In Silico Pharmacology, 12 (1)
  • [22] Exploring the Mechanism of Hawthorn Leaves Against Coronary Heart Disease Using Network Pharmacology and Molecular Docking
    Ding, Jie
    Wu, Jun
    Wei, Haoran
    Li, Sui
    Huang, Man
    Wang, Yan
    Fang, Qin
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] The exploration of the potential mechanism of oxymatrine-mediated antipruritic effect based on network pharmacology and weighted gene co-expression network analysis
    Luo, Zhenhui
    Zhao, Tingting
    Yi, Mengqin
    Wang, Tingting
    Zhang, Zhenglang
    Li, Wenbin
    Lin, Na
    Liang, Shangdong
    Verkhratsky, Alexei
    Nie, Hong
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] Network pharmacology analysis and experimental validation to explore the mechanism of Shenlian extract on myocardial ischemia
    Li, Jing-Jing
    Wang, Chun-Miao
    Wang, Ya-Jie
    Yang, Qing
    Cai, Wei-Yan
    Li, Yu-Jie
    Song, Min
    Zang, Yuan-Long
    Cui, Xi-He
    Li, Qi
    Chen, Ying
    Weng, Xiao-Gang
    Zhu, Xiao-Xin
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2022, 288
  • [25] A Network Pharmacology Approach to Explore Mechanism of Action of Longzuan Tongbi Formula on Rheumatoid Arthritis
    Huang, An
    Fang, Gang
    Pang, Yuzhou
    Pang, Zongran
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [26] Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms
    Wan, Yuxiang
    Xu, Lin
    Liu, Zeyu
    Yang, Ming
    Jiang, Xin
    Zhang, Qiaoli
    Huang, Jinchang
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (1):
  • [27] Network pharmacology analysis and experimental validation to explore the mechanism of Hanchuan Zupa Granule in asthma
    Zhang, Ya-Li
    Yin, Qiang
    Peng, Hui-Ming
    Huang, Rong
    Zhou, Jie-Wen
    Liu, Lin-Hui
    Gao, Han-Qi
    Zhao, Chuan-Peng
    Peng, Xin-Hang
    Xiao, Ling
    Nie, Jing
    Yang, Quan-Cheng
    He, Chun-Ye
    Hu, Gao-Sheng
    Chen, Jia-Chun
    Jia, Jing-Ming
    Fang, Jin-Bo
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2021, 281
  • [28] A Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Pharmacological Mechanism of Astragalus membranaceus for Glioma
    Feng, Yu
    Zhu, Peng
    Wu, Dong
    Deng, Wenbin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [29] A Study Based on Metabolomics, Network Pharmacology, and Experimental Verification to Explore the Mechanism of Qinbaiqingfei Concentrated Pills in the treatment of Mycoplasma Pneumonia
    Liu, Zheng
    Huo, Jin-hai
    Dong, Wen-ting
    Sun, Guo-dong
    Li, Feng-jin
    Zhang, Ya-nan
    Qin, Zhi-wei
    Pengna, Jiang
    Wang, Wei-ming
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [30] Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease
    Liu, Haiyan
    Xu, Jie
    Li, Hui
    Zhang, Lina
    Xu, Pingzhen
    [J]. ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2021, 304 (11): : 2605 - 2619